1. Home
  2. NKTR vs PDEX Comparison

NKTR vs PDEX Comparison

Compare NKTR & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • PDEX
  • Stock Information
  • Founded
  • NKTR 1990
  • PDEX 1978
  • Country
  • NKTR United States
  • PDEX United States
  • Employees
  • NKTR N/A
  • PDEX N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • PDEX Medical/Dental Instruments
  • Sector
  • NKTR Health Care
  • PDEX Health Care
  • Exchange
  • NKTR Nasdaq
  • PDEX Nasdaq
  • Market Cap
  • NKTR 160.4M
  • PDEX 167.6M
  • IPO Year
  • NKTR 1994
  • PDEX N/A
  • Fundamental
  • Price
  • NKTR $0.59
  • PDEX $44.29
  • Analyst Decision
  • NKTR Strong Buy
  • PDEX Strong Buy
  • Analyst Count
  • NKTR 6
  • PDEX 1
  • Target Price
  • NKTR $4.92
  • PDEX $52.00
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • PDEX 64.6K
  • Earning Date
  • NKTR 05-08-2025
  • PDEX 05-01-2025
  • Dividend Yield
  • NKTR N/A
  • PDEX N/A
  • EPS Growth
  • NKTR N/A
  • PDEX 379.10
  • EPS
  • NKTR N/A
  • PDEX 2.76
  • Revenue
  • NKTR $87,248,000.00
  • PDEX $64,123,999.00
  • Revenue This Year
  • NKTR N/A
  • PDEX $28.63
  • Revenue Next Year
  • NKTR N/A
  • PDEX $3.09
  • P/E Ratio
  • NKTR N/A
  • PDEX $16.02
  • Revenue Growth
  • NKTR N/A
  • PDEX 29.65
  • 52 Week Low
  • NKTR $0.43
  • PDEX $16.84
  • 52 Week High
  • NKTR $1.93
  • PDEX $70.26
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 39.04
  • PDEX 36.81
  • Support Level
  • NKTR $0.57
  • PDEX $41.63
  • Resistance Level
  • NKTR $0.81
  • PDEX $70.25
  • Average True Range (ATR)
  • NKTR 0.06
  • PDEX 5.51
  • MACD
  • NKTR -0.01
  • PDEX -2.99
  • Stochastic Oscillator
  • NKTR 7.48
  • PDEX 9.29

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About PDEX Pro-Dex Inc.

Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Share on Social Networks: